Victrex (VCT) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
15 May, 2026Executive summary
Revenue increased 1% year-over-year to £147.1m, driven by 6% volume growth, with a weak Q1 offset by a strong Q2.
Underlying profit before tax (PBT) declined 18% to £19.0m, impacted by adverse mix, pricing pressure, and currency headwinds.
A non-cash impairment of £60.6m was recorded for the China manufacturing facility due to operational limitations, not demand.
Profit improvement plan underway, including a 10% global headcount reduction and new decentralized structure, targeting £10m annualised cost savings by FY 2027.
Interim dividend maintained at 13.42p per share.
Financial highlights
Revenue: £147.1m, up 1% (2% in constant currency), with group sales volume up 6% to 2,137 tonnes.
Gross profit: £61.3m, down 5% year-over-year; gross margin at 41.7%, down 240bps.
Underlying EPS: 17.2p, down 24%; basic loss per share was (37.0p).
Free cash flow: £22m, with cash conversion at 109%.
Net debt: £45.4m, net debt/EBITDA at 0.65x.
Outlook and guidance
FY 2026 underlying PBT expected between £42m–£44m.
Full-year gross margin expected slightly below prior year (45.3%), with H2 improvement anticipated.
Exceptional items for FY 2026 anticipated at £75m–£85m, mainly from China impairment.
CapEx to remain below 8–10% of revenues.
Strategy update and further portfolio review to be communicated at Capital Markets Day in September 2026.
Latest events from Victrex
- Strong FY25 volumes and cash flow, with cost savings and China expansion driving future growth.VCT
Investor presentation - Growth driven by innovation in sustainable PEEK solutions and mega-programme commercialisation.VCT
Investor presentation - Targets c.50% gross margin and 75%+ free cash flow returns to shareholders by FY31.VCT
CMD 2026 - FY 2026 profit outlook raised on strong Q4 growth and cost savings, with strategic divestment completed.VCT
Trading update - Q3 revenue rose 18% year-over-year, with guidance maintained and cost savings underway.VCT
Q3 2026 TU - Net zero by 2050, 53% revenue from sustainable products, and 40% female leadership achieved.VCT
ESG Presentation - 12% volume growth, strong cash flow, but profit down 21% on FX and China costs; GBP 10m savings plan.VCT
H2 2025 - Q3 volumes up 20% year-over-year, but Medical weakness persists amid industry destocking.VCT
Q3 2024 TU - 16% volume growth and strong cashflow drive upgraded FY25 outlook despite FX headwinds.VCT
H1 2025